thalidomide has been researched along with Neoplasms, Skull Base in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cranial nerve involvement in multiple myeloma and solitary plasmacytoma is rare." | 1.36 | Cranial nerve palsy in multiple myeloma and solitary plasmacytoma. ( Kashyap, R; Kumar, R; Kumar, S, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Skamene, S | 1 |
| Rotondo, RL | 1 |
| Shustik, C | 1 |
| Roberge, D | 1 |
| Kashyap, R | 1 |
| Kumar, R | 1 |
| Kumar, S | 1 |
2 other studies available for thalidomide and Neoplasms, Skull Base
| Article | Year |
|---|---|
Necrosis following skull base irradiation and stem cell transplant for multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cranial Irradiation; Dexamethasone; Diphosphonates; | 2010 |
Cranial nerve palsy in multiple myeloma and solitary plasmacytoma.
Topics: Abducens Nerve Diseases; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2010 |